Early Gestational Diabetes Screening in the Gravid Obese Woman

Completed · Not applicable

Conditions studied: Gestational Diabetes, Obesity

In brief

Specific Aim 1: To test the hypothesis that early GDM screening between 14-18 weeks in obese women (body mass index ≥30.0) will result in improved perinatal outcomes. Specific Aim 2: To test the hypothesis that a lower diagnostic threshold for GDM at 14-18 weeks will result in improved detection of GDM and reduce the need for third-trimester testing. Specific Aim 3: To test the hypothesis that 1,5-anhydroglucitol, a sensitive marker of hyperglycemia, can be used as a simple and sensitive serum test for GDM in the obese population.

Key facts

Study ID

NCT01864564

Run by

University of Alabama at Birmingham

People needed

962

Starts

2013-06-18

Expected to finish

2018-08-31

Last updated by the study team

2020-06-23

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant
• 18 years and older
• Body mass index >=30.0
• <20 weeks gestation at presentation for care

You may not qualify if…

• Prior cesarean
• History of bariatric surgery
• Major maternal medical illness (cardiac disease, HIV, hemoglobinopathy, oxygen requirement)
• Chronic prednisone use
• Known fetal anomalies
• Multifetal gestation

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Ochsner Health System — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.